New Study on Global Intravenous (IV) Iron Drugs Market Research Report 2016 | Galenica group, AMAG Pharmaceuticals, Allergan plc.

Researchmoz added Most up-to-date research on "Global Intravenous (IV) Iron Drugs Market Report: 2016 Edition" to its huge collection of research reports.

Iron is vital for multiple bodily functions, most importantly for the production of hemoglobin for red blood cells which are responsible for transporting oxygen in the blood. As an element, the only source of iron is from the diet. There is no way the body can produce iron itself. Intravenous (IV) treatment, in a broad sense, covers all the types of medications delivered intravenously, i.e. directly into the vein, through intravenous drip. Compared to the other routes of infusing medications, the intravenous route is the fastest way to deliver fluids and medications throughout the body. The first iron product for intravenous use was high-molecular-weight iron dextran. Some of the major areas of IV iron application include gynecology, gastroenterology, oncology and surgeries. Hemoglobin, Ferritin, Transferrin, and Hepcidin are major molecules which are critical in the function and regulation of iron.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=731843

The key factors driving growth of the global I.V. iron industry include increase in number of dialysis cases, increasing global healthcare expenditures, rising ageing population, increasing life expectancy rate, growing number of ERSD patients and rising medicines expenditures. Some of the noteworthy trends and developments of this industry are new product development, introduction of the first generation drugs InFed (iron dextran) and Dexeferrum (iron dextra) and feraccru treatment penetration. However, the growth of this sector is being hindered by emerging anemia management therapies and associated risks.

The report analyzes the global iron products industry along with an extensive coverage of global, Europe and the US I.V. iron market. The global IV iron market witnesses intense competition with numerous top notch players; such as Galenica Pharmaceuticals, Actavis Inc, AMAG Pharmaceuticals; operating in the marketplace along with small budding players. As a part of analysis of fierce competition prevailing in the industry, product contention has been presented in the report. The company profiles of leading aforementioned players in the market are also incorporated in the report.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-intravenous-iv-iron-drugs-market-report-2016-edition-report.html/toc

Table of Content

1. Iron in Human Body: An Introduction1.1 I.V. Iron Application Areas
1.1.1 I.V. Iron Application in Nephrology
1.2 Iron Deficiency - Anemia
1.2.1 Iron Deficiency Metrics
1.3 I.V. Iron Therapies for Anemia Treatment
1.4 Types of I.V. Iron

2. Global Iron Product Market Analysis
2.1 Global Iron Product Market by Value
2.2 Global Iron Products Market Share by Segment

3. Global I.V. Iron Drugs Market Analysis
3.1 Global I.V. Iron Drugs Market by Value
3.2 Global I.V. Iron Drugs Market by Product
3.3 Global I.V. Iron Drugs Market Share by Product

4. I.V. Iron Drugs Regional Market Analysis
4.1 European I.V. Iron Drug Market
4.1.1 European I.V. Iron Drug Market by Value
4.1.2 European I.V. Iron Drug Market by Product
4.1.3 European I.V. Iron Drug Market Share by Product
4.2 The US I.V. Iron Drug Market
4.2.1 The US I.V. Iron Drug Market by Value
4.2.2 The US I.V. Iron Drug Market by Product
4.2.3 The US I.V. Iron Drug Market Share by Product
4.2.4 The US Non-dialysis I.V. Iron Drug Market by Volume
4.2.5 The US Non-dialysis I.V. Iron Drug Market Share by Product

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increase in Number of Dialysis Cases
5.1.2 Increasing Healthcare Expenditure
5.1.3 Increasing Cases of CKD and ESRD
5.1.4 Rising Ageing Population
5.1.5 Shift from Rural to Urban Regions
5.1.6 Prevalence of Iron Deficiency in Women
5.1.7 Increasing Life Expectancy Rate
5.1.8 Rising Medicines Expenditures
5.1.9 Growing Number of ERSD Patients
5.2 Trends
5.2.1 New Product Development
5.2.2 Introduction of First Generation Drugs InFeD and Dexeferrum
5.2.3 Feraccru Treatment Penetration
5.3 Challenges
5.3.1 Emerging Anemia Management Therapies
5.3.2 Potential Risks of I.V. Iron

6. Competitive Landscape
6.1 Product Comparison

Continue...

Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=731843

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ https://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.